The blue copper protein caeruloplasmin is synthesized mainly by hepatocytes. An alternative transcript for caeruloplasmin produced in certain extrahepatic tissues, CP-1, contains an additional 12 nucleotides encoding 4 amino acids not present in the hepatic transcript, CP-2 [Yang, Friedrichs, Cupples, Bonifacio, Sanford, Horton & Bowman (1990) 
INTRODUCTION
The human serum glycoprotein caeruloplasmin contains six or seven copper atoms per molecule [1] . These prosthetic copper atoms are necessary for this protein to assist in the mobilization of iron, catalyse oxidation of catecholamines, function in copper transport and delivery, act as an angiogenesis factor (for a review, see [2] ) and for its action as an antioxidant [3] . The many protective and metabolically important roles for caeruloplasmin may account for the increased synthesis of this protein as part of the acute-phase response [4] .
Caeruloplasmin is present in normal human sera in concentrations of 200-350 mg/litre [5] . The major form of caeruloplasmin peptide isolated from human sera has an Mr of 135000 [6] . Two other minor forms of caeruloplasmin peptide are frequently observed: a 115000-Mr peptide derived from the 135 000-Mr form by proteolysis, and another -200 000-Mr form which appears to represent a dimer of the 135 000Mr peptide [7] . These three caeruloplasmin peptides probably contain copper, since they were all present when the copper-containing oxidaseactive holo-caeruloplasmin band resolved by non-denaturing SDS/PAGE was further evaluated by second-dimension electrophoresis [7] .
The liver appears to be the main site of synthesis and secretion of caeruloplasmin [8] . Recent evidence suggests that the major 135 000Mr form of caeruloplasmin peptide is also synthesized by rat sertoli cells [9, 10] and alveolar macrophages [11] , rat mammary glands [12] , mouse embryonic fibroblasts transformed by the Rous-sarcoma virus [13] , human synovial tissue [14] and in human lung (Hs242T) and breast (MCF-7) adenocarcinoma cell lines [12] . Other extrahepatic tissues appear to be able to transcribe caeruloplasmin mRNA [15] [16] [17] [18] [19] [20] ; however, no evidence has yet been presented for the synthesis of holo-caeruloplasmin.
We now report on the extrahepatic biosynthesis of caeruloplasmin by the human endometrium. In the present study we have demonstrated the transcription of caeruloplasmin mRNA by two well-differentiated human uterine epithelial adenocarcinoma cell lines, Ishikawa [21] and ECC1 [22] Caeruloplasmin was isolated from human serum by the method of Morell et al. [23] . Antisera to human caeruloplasmin was prepared in rabbits as previously described [7] . Samples of human endometrium and placenta were collected [24] and human endometrial glands were prepared as described in [25] . The cell lines Ishikawa [21] and ECCI [22] were kindly provided by Dr Ham (DME/F-12) supplemented with 10% FBS and thereafter with phenol-free DMEM/F-12 supplemented with insulin (6.25 4ug/ml), transferrin (6.25 ,ug/ml), sodium selenite (6.25 ,tg/ml), BSA (1.25 mg/ml) and linoleic acid (5.33 jug/ml). ECCI cells were grown overnight in F-12 Ham nutrient mixture supplemented with 10% FBS and thereafter in F-12 Ham nutrient mixture supplemented with glucose (0.4 mg/ml), insulin (9.08 lug/ml), transferrin (25 jug/ml), cholera toxin (10 ng/ml) and oestradiol (0.2 ng/ml).
Metabolic radiolabelling. Confluent cells were washed with sterile phosphate-buffered saline (50 mM-NaH2PO4/150 mmNaCl, pH 7.4) and then incubated in cysteine-free MEM with 10 % dialysed FBS and [35S]cysteine (100-200 ,uCi/ml) for up to 3 h.
Metabolic labelling with 67Cu was performed using confluent cells grown on 100 mm-diameter dishes. Carrier-free 67Cu was added to cells in 5 ml of growth medium (-107 c.p.m./,ug of Cu per ml) and then incubated at 37°C under 5 %-CO2 atmosphere for 14 h.
Protein analysis. Radiolabelled celll lysates or conditioned medium to which phenylmethanesulphonyl fluoride was added to 2 ,LM, were precleaned by incubation with Protein A-Sepharose at 4 'C for 30 min. The suspension was centrifuged, and 25-50 ,ul of Protein A-Sepharose prebound with 50-100 #1 of rabbit anti-(human caeruloplasmin) antisera was added. The suspension was incubated for 2 h at 4°C, then centrifuged (15 000 g, 3 min). The pellet was saved and washed by resuspension in RIPA buffer (4°C) [1.0% (w/v) Triton X-100/0.5% (w/v) sodium deoxycholate/50 mM-Tris/150 mM-NaCl, pH 7.8] and again centrifuged. This was repeated three times with RIPA buffer and then once with 0.15 M-NaCl/10 mM-Tris, pH 7.4 (4 0C). The bound antibody-antigen complex was released from the Protein ASepharose and separated by heating in 50 ,u1 of SDS/PAGE sample buffer at 90°C for 10 min. The heated mixture was centrifuged and the supernatant recovered.
SDS/PAGE was performed as described by Laemmli [26] , using 3 % stacking gels and 7.5 % resolving gels. Gels were prepared for autoradiography by fixation in methanol/acetic acid/water (10:1: 9, by vol.) then incubation in fluorescent enhancer (En3Hance), followed by methanol/acetic acid/water (5:1:14, by vol.) before vacuum drying. Dried gels were exposed to SB-100 film at -70°C.
Peptide mapping of caeruloplasmin was performed using the SDS/PAGE-resolved 135 kDa band of radiolabelled protein recovered by immunoprecipitation. The band was treated with staphylococcal V8 proteinase [27] , the peptides resolved by SDS/PAGE, and the gel prepared for autoradiography as described above.
Transblot ofproteins resolved by SDS/PAGE to nitrocellulose membranes was performed with a buffer of 25 mM-Tris/5.5 % (w/v) glycine/30% (v/v) methanol using a semi-dry blotting apparatus to which 100 mA was applied for 3 h. Western blotting was performed as described by Towbin et al. [28] using a blocking solution of 2 % non-fat dry milk in 10 mM-Tris, pH 7.4, 0.15 M-NaCl, a wash solution containing 0.5 % Tween-20 in 10 mM-Tris, pH 7.4, 0.15 M-NaCl, rabbit anti-(human caeruloplasmin) antisera diluted 1:1000 in blocking solution and 1251. Protein A for detection ofbound antibody. Radiolabelled Protein A was detected by exposure of the dried membranes to XAR-5 film at -70°C.
Secreted proteins from HepG2, Ishikawa and ECCI cells were analysed for copper incorporation into caeruloplasmin after their incubation with growth medium containing "7Cu, as described above. Medium containing radiolabelled protein was partially purified by anion-exchange chromatography using DEAE-20 [23] and concentrated by precipitation with 4 vol. of ethanol at 4 'C. Caeruloplasmin was then resolved by nondenaturing SDS/PAGE, transferred to nitrocellulose membranes, and 67Cu-labelled protein identified by autoradiography [7] . For each individual 67Cu labelling experiment, holo-caeruloplasmin and copper-free apo-caeruloplasmin standards were applied to neighbouring SDS/PAGE lanes and were subjected to Western-blot analysis with rabbit anti-(human caeruloplasmin) antisera, followed by 1251I-Protein A and autoradiography after the decay of the 67Cu (t-60 h).
Nucleic acid techniques. Total RNA from normal human liver, uterus, uterine epithelial glands, placenta, Ishikawa and ECC1 cell lines were prepared as described in [24] .. Total RNA were reverse-transcribed in the presence of 0.2 mm random hexanucleotides as primers using Maloney-murine-Ieukaemia-virus reverse transcriptase (20 units/jig of RNA) in a buffer containing 12 mM-Tris/HCl, pH 8.3, 75 mM-KCl, 35 mM-MgCl2, 15 mMdithiothreitol, acylated BSA (40 ,tg/ml) and 0.7 mm each of the four NTPs for 90 min at 37 'C, followed by 5 min at 90°C for enzyme inactivation. cDNA amplification was performed using 1-2 ,ul aliquots of reverse-transcribed products in the presence of Products of the PCR reaction using caeruloplasmin-specific primers for human liver cDNA and Ishikawa-cell cDNA were ligated with the TA Cloning Vector and used to transform competent Escherichia coli JM109. Colonies containing transformants were selected, and overnight cultures prepared in Luria broth with 25 ,tg of kanamycin/ml for plasmid isolation [29] .
The purified plasmid DNA was utilized for DNA sequencing by the enzymic dideoxy termination method utilizing 35S-ATP for detection of sequence reaction products, and plasmid-specific primers, as previously described [25] . Products of the sequencing reaction were resolved on 6 %-(w/v)-urea/PAGE, and the gel vacuum-dried before autoradiographic exposure. Once the sequence of the cloned amplicon from human liver was determined to be caeruloplasmin (see Fig. 4 below), the insert from this clone obtained by restriction digestion with EcoRl and HindlIl was purified and utilized as a probe for Southern blotting.
PCR products resolved by 2 %-(w/v)-agarose-gel electrophoresis were denatured and transferred to nylon membranes by vacuum blotting, then utilized for Southern blotting as previously described [25] [7] was seen only in HepG2 (lanes 1 and 2) .
ECCI demonstrate the synthesis and secretion of caeruloplasmin (Fig. la) . Caeruloplasmin recovered for both cell lysates and medium of Ishikawa cells had an Mr identical with that of caeruloplasmin synthesized by HepG2 cells (Fig. lb) , although the amount of caeruloplasmin synthesized by Ishikawa cells appears to be less than that of HepG2, since comparable numbers of cells were utilized for this experiment. Synthesis of a mature 135000-M, form of caeruloplasmin by Ishikawa and ECC1 cells (Fig. la) , comparable with that of HepG2 cells (Fig. lb) , suggests similar processing of this protein by these cell lines.
Peptide mapping was performed on proteinase-treated Ishikawa-cell-derived caeruloplasmin for comparison with the corresponding protein synthesized by HepG2 (Fig. 2) . The Ishikawaand HepG2-cell caeruloplasmins were found to give peptide patterns identical with those of-the proteins originally isolated from human sera [71. This indicates that the primary structures of the uterine-derived and human serum proteins are identical.
Transcription of caeruloplasmin mRNA by uterine tissue and Ishikawa cells
Active transcription of caeruloplasmin mRNA by Ishikawa cells, uterine endometrium, purified endometrial-gland cells, placenta and liver was demonstrated by the presence of PCR products obtained using caeruloplasmin specific primers and cDNA from these sources (Fig. 3a) . The identity of these PCR products was confirmed by Southern-blot analysis, demonstrating hybridization with a cDNA probe specific for human caeruloplasmin (Fig. 3b). DNA sequencing of the cloned caeruloplasmin PCR products obtained from Ishikawa cells and-human liver (Fig. 4) Vol. 288 plasmin transcripts occurs in liver and uterine endometrial tissue.
Metabolic incorporation of copper into caeruloplasmin by uterine cell lines
The biosynthetic incorporation of copper into caeruloplasmin was demonstrated for Ishikawa, ECC and HepG2 cells by metabolic radiolabelling of the protein with 67Cu (Fig. 5) . The radiolabelled protein, detected by autoradiography of the transblot, was identified as the copper-containing protein holocaeruloplasmin by its characteristic migration on non-denaturing SDS/PAGE ( Fig. 5 ; [7] ). The differential migration ofthe purified human serum apo-and holo-caeruloplasmin standards, present on adjacent lanes of the same transblot as the [67Cu]caeruloplasmin, were identified by Western-blot analysis using 1251-Protein A for detection of bound antibody once the 67Cu had decayed (67Cu ti = 60 h) (Fig. 5) .
DISCUSSION
We now provide the first evidence for the active transcription, translation and secretion of caeruloplasmin protein by two uterine epithelial cell lines and for its transcription by human uterine endometrial tissue and placenta. Caeruloplasmin synthesized by the uterine cell lines (Figs. la and lb) was observed to be of the same Mr as that normally present for these proteins within the circulation, and the same as that synthesized by HepG2 cells (Fig. lb) . Peptide mapping of caeruloplasmin synthesized by Ishikawa cells showed identity with the corresponding HepG2 protein (Fig. 2) . Furthermore, DNA sequence analysis corresponding to partial transcripts of caeruloplasmin from Ishikawa cells and human liver (Fig. 4) indicates identity with previously reported sequences for this protein [20, 30] . Therefore it is likely that the primary structure and intracellular processing of these proteins is similar for uterine epithelial cells and hepatocytes.
Copper-containing holo-caeruloplasmin isolated from human serum can be identified by its characteristic migration and preserved oxidase activity on non-denaturing SDS/PAGE and transblot [7] . We have demonstrated that the two uterine cell lines studied are capable of synthesizing [67Cu]caeruloplasmin (Fig. 5) , indicating that uterine cells possess the necessary intracellular machinery to incoporate copper into this protein.
That this process is not unique to hepatocytes has never before been demonstated for caeruloplasmin synthesized by non-hepatic cells [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . That the 67Cu is fortuitously bound by the caeruloplasmin synthesized by these cells is unlikely, since the exchange of copper into caeruloplasmin requires very specific non-physiological conditions [31] . The process of copper incorporation into caeruloplasmin must involve copper transport across cellular and intracellular membranes and insertion of the metal into binding sites either co-translationally or immediately post-translationally. At present we can only assume that the stoichiometry of the copper binding of uterine caeruloplasmin is the full six or seven copper molecules per caeruloplasmin molecule [1] and that these copper atoms contain the same multiplicity of oxidation states as caeruloplasmin synthesized by hepatocytes.
Two distinct human caeruloplasmin transcripts have been reported [20, 30] . The transcript CP-2 is the main transcript present in liver tissue and encodes the amino acid sequence for caeruloplasmin isolated from human sera. We have found this to be the transcript produced by our sample of human liver and by Ishikawa cells (Fig. 4) . Therefore the alternative splicing which was postulated to have produced the caeruloplasmin transcript CP-l in certain extrahepatic tissues [30] probably does not occur in uterine tissue.
The transcription of caeruloplasmin mRNA by human uterine endometrial tissue and its reported presence in rat uterus [17] strongly suggest that the synthesis of this protein by Ishikawa The uterine endometrial lining cells have been shown to contribute actively towards the creation of a unique microenvironment within the uterus in preparation for embryonic development, synthesizing growth factors, prostaglandins and even interferons [32, 33] . Their synthesis of caeruloplasmin may be important for cell growth, for cellular iron utilization and for its antioxidant action. The availability of hormonally responsive non-hepatic cell lines able to synthesize caeruloplasmin, such as Ishikawa and ECCI, will offer opportunities to study the regulation of caeruloplasmin biosynthesis.
